Why It’s Worth It | Live to be 120! No, 150! Eat this, but not this! Take this, not that! How much of what we’re doing in the name of longevity actually has evidence behind it? How many of the supplements, doctor visits, and protocols we’re paying for are doing nothing (except costing us)? And what would it look like to replace all of it with something that actually works?
In this episode of Rethinking, host Adam Grant sits down with cardiologist and one of the ten most cited living scientists in medicine, Eric Topol, to sort signal from noise in the longevity space. Drawing on his book Superagers and decades of research, Eric makes a clear-eyed case for what the evidence actually supports: not supplements, not total body MRIs, not rapamycin, but a precision medicine approach to preventing the three diseases that cut most lives short, paired with lifestyle habits that genuinely move the needle.
Eric opens with a finding that stopped him cold. After seven years of recruiting and sequencing the genomes of 1,400 people aged 85 and older who had never had a major age-related disease, he and his team found almost nothing genetically different about them compared to people aging poorly. Most of them had parents and siblings who died 20 years younger. The genes weren’t the story. What emerged instead was a picture of the immune system: specifically, that these superagers appeared to carry an unusually robust immune response, one shaped heavily by lifestyle rather than inheritance. The implication is both humbling and genuinely hopeful. More of our healthspan is in our hands than we assumed.
From there, Adam invites Eric into territory he is clearly delighted to enter: debunking the longevity industry. The list is brisk and specific. Supplements claiming anti-aging benefits have no meaningful data behind them. Longevity clinics charging up to $250,000 for treatments like plasma infusions and hyperbaric oxygen have no rigorous evidence either. Total body MRIs, far from catching cancer early, often trigger invasive biopsies for findings that turn out to be harmless, and can cause serious complications in the process. Rapamycin, which works well in mice, has no human data and risks meaningful immune suppression. And the protein craze (Eric notes with particular feeling) can push roughly twice the recommended amount, resulting in high animal protein intake, potentially driving inflammation and atherosclerosis.
Eric then steers toward what does work, and it centers on a concept most of us underestimate: the 20-year runway. Heart disease, Alzheimer’s, and most cancers spend two decades quietly developing before a diagnosis arrives. That window, he argues, is where medicine should be operating, and largely isn’t. New tools, including polygenic risk scores, genome sequencing, blood-based cancer detection, and AI analysis of retinal scans, can now identify who is at elevated risk for each of the big three diseases, sometimes long before any symptom appears. Early detection at the microscopic level, he notes, is categorically different from catching a mass on an MRI. In some cases, the immune system will clear tumor DNA on its own once identified, or can be supported to do so.
On exercise, Eric and Adam agree it should be refreshingly grounded. The zone debates, he suggests, are mostly noise. The evidence supports moving consistently, mixing aerobic activity with resistance training and balance work, and making it enjoyable enough to sustain. On sleep, which comes up in the lightning round, Eric flags it as underappreciated across all age-related disease categories, particularly neurodegenerative ones, and recommends tracking it to understand what actually affects quality. And when Adam presses on immortality, cryonics, and AI-enabled drug discovery ending all disease, Eric is gently direct: aging is a process, not a problem to be solved, and prevention remains a far more realistic frontier than reversal.
Background | In this episode, Adam speaks with Eric Topol, a cardiologist at Scripps Research, one of the ten most cited living scientists in medicine, and the author of Superagers: An Evidence-Based Approach to Longevity. Key takeaways include:
- The superager surprise: Genome sequencing of 1,400 people who reached 85-plus with no major disease found almost no genetic distinction from those aging poorly. The differentiator appears to be immune system health, which lifestyle shapes far more than genetic inheritance does.
- The 20-year runway: Heart disease, Alzheimer’s, and most cancers spend two decades developing before diagnosis. Polygenic risk scores, genome markers, and blood-based cancer detection can now identify who is at risk, and when, long before symptoms appear. That window is where prevention lives.
- What the longevity industry gets wrong: Supplements, plasma infusions, hyperbaric chambers, and rapamycin share one thing: no rigorous human evidence. Total body MRIs often cause more harm than good. High-protein regimens recommend roughly double what the research actually supports.
- Exercise optimized: Zone debates aside, the evidence supports consistent movement that combines aerobic activity, resistance training, and balance work, especially as we age. Making it genuinely enjoyable is not a nice-to-have. It is the mechanism by which we sustain it.
- Sleep is the underrated lever: Most people are not getting high-quality sleep, and the downstream effects touch nearly every age-related disease category, particularly neurodegenerative ones. Tracking sleep patterns against diet, timing, and exercise can reveal what is actually disrupting it.
- Prevention over treatment: Twelve million major diagnostic errors occur in the US each year. Our treatment toolkit for most cancers has changed remarkably little. The frontier where real gains are possible is not better cures; it is identifying and intervening before the disease gets legs.
About | Adam Grant is a well-known organizational psychologist and wildly popular Wharton professor. He is an accomplished writer, a profound thinker, and a thorough researcher, covering various subjects to help people discover purpose and motivation and lead more creative and generous lives. Adam’s content includes New York Times bestsellers, TED podcasts and talks, columns in various publications, and GRANTED, a free email newsletter (sign up on his website!). Adam encourages us to constantly question our ideas and rethink our beliefs.
Source | Rethinking: Busting Longevity Myths with Eric Topol – December 9, 2025




